The fusion of technology and biology is known as biotechnology. It covers a broad variety of practises such as agriculture, medicine, and food production that alter living things for human needs. Using biological systems and creatures, biotechnology is employed in the pharmaceutical business to develop novel therapies for illnesses. Cancer, metabolic disorders, gene therapy, and infectious disease are the areas where biotechnology is most frequently applied. The most effective biotechnology medications available today address a variety of diseases, including arthritis, Crohn's disease, psoriatic arthritis, colitis, lymphoma, leukaemia, diabetes, kidney cancer, cervical cancer, and ovarian cancer. Vaccines, nucleic acid products, and antibodies are examples of bioformulations that make up the bulk of therapeutic medications on the market today. Understanding the essential mechanisms involved establishing the purpose of related biomolecules, their synthesis and purification, evaluation of the product's shelf life, stability, toxicity, and immunogenicity, development of drug delivery systems, patenting, and clinical trials are all steps in the development of such bioformulations.
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami, United States
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N D Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : R&D consultancy at the medicines discovery catapult: De-risking drug discovery for innovators
Adriana Gambardella, Medicine Discovery Catapult, United Kingdom
Title : Biocompatible synthesis of non crystalline iron oxide nanoparticles with stable colloidal properties
Lan Wang, Paretor LLC, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Biocompatibility and subcutaneous host response to silk fibroin–chitosan composite plugs: Progress toward biodegradable implant materials
Luis Jesus Villarreal Gomez, Universidad Autónoma de Baja California, Mexico